Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

35 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Model-based cost-effectiveness analyses for the treatment of acute stroke events: a review and summary of challenges.
Earnshaw SR, Wilson M, Mauskopf J, Joshi AV. Earnshaw SR, et al. Value Health. 2009 Jun;12(4):507-20. doi: 10.1111/j.1524-4733.2008.00467.x. Epub 2008 Nov 10. Value Health. 2009. PMID: 19900253 Review.
Economic efficiency of genetic screening to inform the use of abacavir sulfate in the treatment of HIV.
Kauf TL, Farkouh RA, Earnshaw SR, Watson ME, Maroudas P, Chambers MG. Kauf TL, et al. Among authors: earnshaw sr. Pharmacoeconomics. 2010;28(11):1025-39. doi: 10.2165/11535540-000000000-00000. Pharmacoeconomics. 2010. PMID: 20575592
Cost-effectiveness of CT perfusion for selecting patients for intravenous thrombolysis: a US hospital perspective.
Jackson D, Earnshaw SR, Farkouh R, Schwamm L. Jackson D, et al. Among authors: earnshaw sr. AJNR Am J Neuroradiol. 2010 Oct;31(9):1669-74. doi: 10.3174/ajnr.A2138. Epub 2010 Jun 10. AJNR Am J Neuroradiol. 2010. PMID: 20538823
Factor VIII alloantibody inhibitors: cost analysis of immune tolerance induction vs. prophylaxis and on-demand with bypass treatment.
Earnshaw SR, Graham CN, McDade CL, Spears JB, Kessler CM. Earnshaw SR, et al. Haemophilia. 2015 May;21(3):310-9. doi: 10.1111/hae.12621. Epub 2015 Feb 16. Haemophilia. 2015. PMID: 25688580
Cost-effectiveness of bisphosphonate therapies for women with postmenopausal osteoporosis: implications of improved persistence with less frequently administered oral bisphosphonates.
Earnshaw SR, Graham CN, Ettinger B, Amonkar MM, Lynch NO, Middelhoven H. Earnshaw SR, et al. Curr Med Res Opin. 2007 Oct;23(10):2517-29. doi: 10.1185/030079907X226339. Curr Med Res Opin. 2007. PMID: 17825128 Clinical Trial.
Methylnaltrexone bromide for the treatment of opioid-induced constipation in patients with advanced illness--a cost-effectiveness analysis.
Earnshaw SR, Klok RM, Iyer S, McDade C. Earnshaw SR, et al. Aliment Pharmacol Ther. 2010 Apr;31(8):911-21. doi: 10.1111/j.1365-2036.2010.04244.x. Epub 2010 Jan 20. Aliment Pharmacol Ther. 2010. PMID: 20096019
Are We Ready to Use Constrained Optimization in Health Outcomes Research?
Earnshaw SR. Earnshaw SR. Value Health. 2018 Sep;21(9):1029-1030. doi: 10.1016/j.jval.2018.07.004. Epub 2018 Aug 9. Value Health. 2018. PMID: 30224104 Free article. No abstract available.
Cost-effectiveness model for neovascular age-related macular degeneration: comparing early and late treatment with pegaptanib sodium based on visual acuity.
Javitt JC, Zlateva GP, Earnshaw SR, Pleil AM, Graham CN, Brogan AJ, Shah SN, Adamis AP. Javitt JC, et al. Among authors: earnshaw sr. Value Health. 2008 Jul-Aug;11(4):563-74. doi: 10.1111/j.1524-4733.2007.00283.x. Epub 2007 Dec 17. Value Health. 2008. PMID: 18179676 Clinical Trial.
Cost-effectiveness of fluticasone propionate/salmeterol (500/50 microg) in the treatment of COPD.
Earnshaw SR, Wilson MR, Dalal AA, Chambers MG, Jhingran P, Stanford R, Mapel DW. Earnshaw SR, et al. Respir Med. 2009 Jan;103(1):12-21. doi: 10.1016/j.rmed.2008.10.005. Epub 2008 Nov 17. Respir Med. 2009. PMID: 19010652
Cost-effectiveness of Maintaining Daily Intake of Oat β-Glucan for Coronary Heart Disease Primary Prevention.
Earnshaw SR, McDade CL, Chu Y, Fleige LE, Sievenpiper JL. Earnshaw SR, et al. Clin Ther. 2017 Apr;39(4):804-818.e3. doi: 10.1016/j.clinthera.2017.02.012. Epub 2017 Mar 25. Clin Ther. 2017. PMID: 28347513 Free article.
35 results
Jump to page